Evidence map›Paper›PMID 28265556›Full record

ReviewFrontiers in pediatrics2017

The Epidemiology of Chronic Suppurative Lung Disease and Bronchiectasis in Children and Adolescents.

Gabrielle B McCallum, Michael J Binks

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Frontiers in pediatrics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04765033 (Efficacy of Nebulised 5% Hypertonic Saline in Children With Chronic Suppurative Lung Disease), which is not on this map. Cited by 49 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 2 pooled it
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04765033 phase4completednot on this mapstarted 2021, after this paper: background citation

Efficacy of Nebulised 5% Hypertonic Saline in Children With Chronic Suppurative Lung Disease

TypeinterventionalSponsorUniversity of MalayaRan2021 to 2023Enrolled46ConditionsBronchiectasisArmsNebulized 5% Hypertonic saline
3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 2 syntheses or guidelines pooled it, 112 citations in OpenAlex.

  1. Mucolytics for children with chronic suppurative lung disease.The Cochrane database of systematic reviews · 2025
    Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Hyperconcentrated mucus in small airways: a mechanistic model for the pathogenesis of paediatric bronchiectasis.European respiratory review : an official journal of the European Respiratory Society · 2025
    Review
  10. Review
  11. Observational
  12. Article
  13. OvercomingAntibiotics (Basel, Switzerland) · 2025
    Review
  14. Review
  15. Article
  16. Observational
  17. Article
  18. Article
  19. Article
  20. Bronchiectasis in children in a high HIV and tuberculosis prevalence setting.African journal of thoracic and critical care medicine · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Gabrielle B McCallumChild Health Division, Menzies School of Health Research, Charles Darwin University , Darwin, NT , Australia.
Michael J BinksChild Health Division, Menzies School of Health Research, Charles Darwin University , Darwin, NT , Australia.
Charles Darwin University · AUMenzies School of Health Research · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the modern era, the global burden of childhood chronic suppurative lung disease (CSLD) remains poorly captured by the literature. What is clear, however, is that CSLD is essentially a disease of poverty. Disadvantaged children from indigenous and low- and middle-income populations had a substantially higher burden of CSLD, generally infectious in etiology and of a more severe nature, than children in high-income countries. A universal issue was the delay in diagnosis and the inconsistent reporting of clinical features. Importantly, infection-related CSLD is largely preventable. A considerable research and clinical effort is needed to identify modifiable risk factors and socioeconomic determinants of CSLD and provide robust evidence to guide optimal prevention and management strategies. The purpose of this review was to update the international literature on the epidemiology, etiology, and clinical features of pediatric CSLD.

Indexed as

bronchiectasischildrenchronic suppurative lung diseaseepidemiologyetiology

Identifiers

PMID28265556
PMCPMC5316980
OpenAlexW2589308406

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.